Spreading Depolarization and Ketamine Suppression

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

January 1, 2017

Study Completion Date

May 1, 2017

Conditions
Cortical Spreading DepolarizationCortical Spreading DepressionSubarachoid HemorrhageTraumatic Brain Injury
Interventions
DRUG

ketamine

Ketamine will be used as a sedative alternative to other more conventional sedatives (such as propofol, versed, or dexmedetomidine) in 6 hour blocks of time. Ketamine will be titrated at the bedside based on clinically desired Riker Sedation-Agitation Scale target. Both groups will receive the drug in this multiple crossover design. The only difference between groups is which sedation regimen is started first to minimize any bias related to differences in physiology in the early post-operative phase.

Trial Locations (1)

87131

University of New Mexico, Albuquerque

All Listed Sponsors
lead

University of New Mexico

OTHER

NCT02501941 - Spreading Depolarization and Ketamine Suppression | Biotech Hunter | Biotech Hunter